An experimental Zika vaccine lowered levels of virus in pregnant monkeys and improved fetal outcomes in a rhesus macaque model of congenital Zika virus infection, according to a new study in Science Translational Medicine.
Diseases
Efforts to end the HIV epidemic must not ignore people already living with HIV
NIH experts have highlight that efforts to prevent new HIV transmissions in the United States must be accompanied by advances in addressing HIV-associated comorbidities to improve the health of people already living with HIV,
Short-term exposure to air pollution linked with new causes of hospital admissions, substantial economic costs
Hospitalizations for several common diseases—including septicemia (serious bloodstream infection), fluid and electrolyte disorders, renal failure, urinary tract infections, and skin and tissue infections—have been linked for the first time with short-term exposure to fine particulate air pollution (PM2.5), according to a comprehensive new study led by Harvard T.H. Chan School of Public Health.
ERVEBO® [Ebola Zaire Vaccine] Awarded Prequalification Status by the World Health Organization (WHO)
MERCK (NYSE: MRK), known as MSD (www.MSD.com) outside the United States and Canada, today announced that ERVEBO [Ebola Zaire Vaccine (rVSVΔ-ZEBOV-GP live)] has been awarded prequalification status by the World Health Organization (WHO).
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world.
Ebola vaccine approved in Europe
After more than two decades of research, the world finally has an approved Ebola vaccine.
Research shows using both marijuana and alcohol during early pregnancy may disrupt fetal development
New preclinical research reported in animal models shows that exposure to compounds found in marijuana called cannabinoids (CBs), which includes cannabidiol (CBD) and tetrahydrocannabinol (THC), during early pregnancy can cause malformations in the developing embryo.
